The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Mechanism of Action of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole), A New Broad-Spectrum Antiviral Agent
Open accessAbstract
The antiviral activity of the synthetic nucleoside, Virazole (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), against measles virus in Vero cell cultures was substantially reversed by xanthosine, guanosine, and to a slightly lesser extent by inosine. Virazole 5′-phosphate was subsequently found to be a potent competitive inhibitor of inosine 5′-phosphate dehydrogenase (IMP:NAD + oxidoreductase, EC 1.2.1.14) isolated from Escherichia coli ( K m = 1.8 × 10 -5 M) with a K i of 2.7 × 10 -7 M. Guanosine 5′-phosphate (GMP) was a competitive inhibitor of this enzyme with a K i of 7.7 × 10 -5 M. Virazole 5′-phosphate was similarly active against IMP dehydrogenase isolated from Ehrlich ascites tumor cells, with a K i of 2.5 × 10 -7 M. The K m for this enzyme was 1.8 × 10 -5 M, and the K i for GMP was 2.2 × 10 -4 M. These results suggest that the antiviral activity of Virazole might be due to the inhibition of GMP biosynthesis in the infected cell at the step involving the conversion of IMP to xanthosine 5′-phosphate. This inhibition would consequently result in inhibition of the synthesis of vital viral nucleic acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
Sidwell, R. W., Huffman, J. H., Khare, L., Allen, B., Witkowski, R., & Robins, K. (1972) · Science · doi:10.1126/science.177.4050.705 · Cited by 985
Self-citationA novel method for phosphorylation of nucleosides to 5′-nucleotides
Yoshikawa, M., Kato, T., & Takenishi, T. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)89915-9 · Cited by 491
Witkowski, J. T., Robins, R. K., Sidwell, R. W., & Simon, L. N. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00281a014 · Cited by 471
Self-citationThe inhibition of nucleic acid synthesis by mycophenolic acid
Franklin, T. J., & Cook, J. M. (1969) · Biochemical Journal · doi:10.1042/bj1130515 · Cited by 368
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Furuta, Y., Gowen, B. B., Takahashi, K., Shiraki, K., Smee, D. F., & Barnard, D. L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.015 · Cited by 1,072
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070
RNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 820
Mechanisms of action of ribavirin against distinct viruses
Graci, J. D., & Cameron, C. E. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.483 · Cited by 549
Mechanism of Action of T-705 against Influenza Virus
Furuta, Y., Takahashi, K., Kuno-Maekawa, M., Sangawa, H., Uehara, S., Kozaki, K., Nomura, N., Egawa, H., & Shiraki, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.981-986.2005 · Cited by 546
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanabe, Y., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.977-981.2002 · Cited by 501
Smith, E. C., Blanc, H., Vignuzzi, M., & Denison, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003565 · Cited by 444
The design of drugs for HIV and HCV
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2424 · Cited by 430
Characterization of human type I and type II IMP dehydrogenases.
Carr, S. F., Papp, E., Wu, J. C., & Natsumeda, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74247-1 · Cited by 403
Maag, D., Castro, C., Hong, Z., & Cameron, C. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100349200 · Cited by 281
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
Hoffmann, H.-H., Kunz, A., Simon, V. A., Palese, P., & Shaw, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101143108 · Cited by 266
Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate
Eriksson, B., Helgstrand, E., Johansson, N. G., Larsson, A., Misiorny, A., Noren, J. O., Philipson, L., Stenberg, K., Stening, G., Stridh, S., et al. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.6.946 · Cited by 257
Arnold, J. J., & Cameron, C. E. (2004) · Biochemistry · doi:10.1021/bi035212y · Cited by 178
SAIJO, M., MORIKAWA, S., FUKUSHI, S., MIZUTANI, T., HASEGAWA, H., NAGATA, N., IWATA, N., & KURANE, I. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.01.003 · Cited by 82
Metadata
- Authors
- Streeter, D. G., Witkowski, J. T., Khare, G. P., Sidwell, R. W., Bauer, R. J., Robins, R. K., & Simon, L. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1973-04
- Volume
- 70
- Issue
- 4
- Pages
- 1174-1178
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079066605
- Cited by
- 478
- References
- 4
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.